Εμφάνιση αναρτήσεων με ετικέτα FIP. Εμφάνιση όλων των αναρτήσεων
Εμφάνιση αναρτήσεων με ετικέτα FIP. Εμφάνιση όλων των αναρτήσεων

Δευτέρα 22 Ιουνίου 2026

Λοιμώδης περιτονίτιδα της γάτας (FIP): τελευταία νέα, για κτηνιάτρους και φροντιστές που θέλουν να ξέρουν

 











FIP (Feline Corona Virus) is caused by a mutation of the feline coronavirus (FCoV). It progresses quickly, and untreated cases are almost always fatal within weeks. Yet many clinics still default to lengthy, stepwise workups, sometimes including referral to a second-opinion internal medicine specialist, before confirming the diagnosis. 

The reasons are understandable. FIP can mimic other diseases (lymphoma, cholangiohepatitis, toxoplasmosis, cardiomyopathy), and no single test gives a 100% definitive answer in every case. But waiting for absolute diagnostic certainty is the most common mistake owners encounter. By the time biopsy results return, the cat may have lost critical ground.

The modern approach, used by FIP-experienced vets, is to combine pattern recognition (signalment, symptoms, bloodwork) with targeted confirmatory tests, and to start the 84-day antiviral protocol as soon as the clinical picture is convincing. 



Before any test, your vet will consider the patient. Classic FIP risk factors include:

1. Age under 2 years (though older cats can develop it).

2. Recent stressor: rehoming, neutering, vaccination, boarding, or new household member.

3. Multi-cat origin: shelters, rescues, breeders, ferals.

4. Pedigree breeds, particularly Birmans, Ragdolls, Bengals, British Shorthairs and Maine Coons.

5. Persistent fever unresponsive to antibiotics. 

6. Failure to thrive in a young cat.

If your cat matches several of these, you should ask your vet directly: "Could this be FIP, and what is the fastest way to find out?" 



FIP does not present the same way in every cat. UK vets typically classify it into four types, and the diagnostic pathway differs slightly for each.

1. Wet (Effusive) FIP: The most recognisable form. Fluid accumulates in the abdomen (most common), chest, or pericardium. Cats often have a distended belly, laboured breathing, lethargy and weight loss despite a swollen appearance. Diagnosis is usually the fastest here, because the effusion itself can be sampled and tested.

2. Dry (Non-Effusive) FIP: No significant fluid. Instead, granulomas form in organs such as the kidneys, liver, intestines or lymph nodes. Symptoms are vaguer: chronic fever, weight loss, jaundice, palpable masses. Diagnosis is harder and relies more on bloodwork, imaging and sometimes fine-needle aspiration of affected tissue.

3. Ocular FIP: The eye is affected, often as the first visible sign. Look for colour change in the iris, cloudiness, uveitis, keratic precipitates (small deposits on the inside of the cornea), or sudden blindness. An ophthalmic exam combined with systemic bloodwork is usually diagnostic.

4. Neurological FIP: The most dangerous form to delay. Signs include wobbliness (ataxia), seizures, head tilt, behavioural change, incontinence, or hind-limb weakness. Diagnosis may involve MRI and cerebrospinal fluid (CSF) analysis if available, but in practice many UK vets diagnose neurological FIP on clinical signs plus supportive bloodwork, because waiting for imaging can be fatal. If you take nothing else from this guide, take this: a standard haematology and biochemistry panel, run in-house or at a UK reference lab, gives most of what is needed to suspect FIP within 24 hours.



Ask your vet to look specifically at:

1. Globulins and the A/G RatioFIP cats typically have elevated globulins (often above 51 g/L) and low albumin, producing a low albumin-to-globulin ratio. An A/G ratio below 0.6 is highly suggestive of FIP. Above 0.8, FIP becomes less likely (though not impossible).

2. Total ProteinOften elevated due to the globulin spike, despite the cat being clinically wasted.

3. Lymphocytes: Lymphopenia (low lymphocyte count) is very common in FIP.

4. Bilirubin: Elevated bilirubin without obvious haemolysis or biliary obstruction is a red flag, especially in a young cat with fever.

5. ALT and Liver EnzymesMild to moderate elevations are common. ALT is also one of the markers tracked week by week during the 84-day antiviral protocol.

6. SDMA and Kidney MarkersSDMA, creatinine and urea help establish renal baseline before treatment, which matters because dosing and monitoring depend on kidney function.

7. Haematocrit: Mild non-regenerative anaemia is typical.

A young cat with fever, weight loss, low A/G ratio, elevated bilirubin and lymphopenia is, until proven otherwise, an FIP suspect. That single pattern can justify starting treatment in many clinics that are experienced with FIP. 



For suspected wet or dry FIP, abdominal ultrasound is the most useful single imaging test. It detects:

1. Free abdominal fluid (even small volumes invisible on X-ray).

2. Enlarged mesenteric lymph nodes.

3. Kidney capsule changes ("granulomatous nephritis").

4. Intestinal wall thickening.

5. Liver or splenic nodules.


Thoracic X-ray or Ultrasound: If breathing is laboured, this rules in or out pleural effusion or pericardial fluid.


MRIReserved for neurological cases at referral centres. Useful but rarely essential. Most UK owners cannot wait the days or weeks for a referral slot, and most FIP-experienced vets will start treatment based on bloodwork plus neurological exam. 



If there is any abdominal or chest fluid, sampling it is the single most powerful diagnostic step. A small needle tap (often done conscious or with light sedation) gives fluid that can be tested immediately.

Appearance: FIP effusion is classically straw-yellow, viscous, and may froth slightly when shaken (due to high protein content).

Protein Content: FIP effusions are exudates with very high protein (typically above 35 g/L).

Cell Count: Low to moderate, predominantly macrophages and neutrophils. A low cell count with high protein is a hallmark.

The Rivalta TestA simple, low-cost test that many UK clinics can perform in minutes. A drop of effusion is added to a tube of distilled water with one drop of acetic acid. If the drop holds its shape and slowly sinks, the test is positive (suggestive of FIP). If it dissolves, it is negative. A positive Rivalta test in a young cat with classic bloodwork is, for most FIP-experienced clinicians, sufficient to begin treatment. 

PCR on EffusionReverse transcription PCR (RT-PCR) for feline coronavirus on effusion fluid is highly specific. A positive PCR on abdominal or chest fluid is essentially confirmatory in a clinically suspect cat. UK reference labs such as Langford Vets and IDEXX offer this test, with turnaround typically 2 to 5 working days. 



Histopathology with immunohistochemistry on affected tissue remains the gold standard. But here is the honest reality for UK owners: biopsy is invasive, expensive, requires general anaesthesia in a cat already weakened by disease, and the results take a week or more.

In modern FIP practice, biopsy is reserved for:

1. Cats with no effusion and no clear ultrasound abnormality.

2. Cases where bloodwork is genuinely ambiguous (lymphoma is the main differential).

3. Suspected dry FIP where a palpable mass can be safely aspirated.

Fine-needle aspiration of an enlarged lymph node or organ lesion, sent for cytology with PCR, is a much faster and less invasive alternative and is increasingly used in the UK. 



A well-coordinated FIP workup looks like this:

Day 1: Clinical exam, full bloodwork (haematology, biochemistry, A/G ratio, SDMA, bilirubin), urinalysis, abdominal ultrasound. If effusion present, sample it. Run Rivalta in clinic. Send fluid for PCR and protein analysis.

Day 2 to 3: Bloodwork interpretation. If pattern fits FIP, many experienced vets will start the 84-day antiviral protocol immediately rather than wait for PCR.

Day 4 to 7: PCR result returns. Treatment continues or is adjusted based on response.

If your clinic is recommending a longer pathway with multiple referrals before any treatment, and your cat is visibly deteriorating, it is reasonable to seek a second opinion from a vet experienced in FIP management. 

Once FIP is confirmed or strongly suspected, the priority shifts to starting GS-441524, the antiviral that revolutionised FIP outcomes after the work of Dr. Niels Pedersen at UC Davis

The Pedersen 2019 study reported a 92% success rate with GS-441524 injectable monotherapy. 


_______________________________________________________

CureFIP™ offers three injectable strengths so dosing can be matched to your cat's weight and FIP type:

1. CureFIP™ GS-441524 Injectable 20mg/ml at €79.00, available in 8ml and 10ml.

2. CureFIP™ GS-441524 Injectable 30mg/ml at €89.00, available in 8ml and 10ml.

3. Cure FIP Antiviral 40mg/ml at €119.00, available in 8ml and 10ml. 

For owners who prefer an oral route, the CURE FIP™ Dual Antiviral Oral Capsules at €179.00 combine GS-441524 with EIDD-1931. Dosing by weight: under 2.5 kg uses GS-441524 25 mg plus EIDD-1931 5 mg; 2.5 to 5 kg uses GS-441524 35 mg plus EIDD-1931 8 mg; over 5 kg uses GS-441524 50 mg plus EIDD-1931 12 mg. One capsule daily for the recommended 12 weeks. The dual oral protocol has shown a 78.3% remission rate (Li and Cheah 2025). Note: the oral dual route is positioned for wet and dry FIP and is not recommended once ocular or neurological signs are present, or when the cat cannot eat or defecate.

Your vet will help you choose the right product and strength based on weight, FIP type, and clinical condition. 



Diagnosis is only the start. Throughout the 84-day protocol, your vet should repeat bloodwork roughly every 3 to 4 weeks to track:

1. Globulins and A/G ratio (should normalise).

2. ALT and bilirubin (should fall).

3. Haematocrit and lymphocytes (should recover).

4. SDMA and creatinine (should remain stable).

Week by week improvement on these markers is one of the strongest predictors of remission. 



FIP is diagnosed through a combination of clinical signs, bloodwork (low A/G ratio, elevated globulins and bilirubin, lymphopenia), imaging (ultrasound for effusion or organ lesions), effusion analysis (Rivalta test, protein, cytology), and RT-PCR for feline coronavirus on fluid or tissue. No single test is required, and most experienced vets diagnose based on a convincing pattern rather than waiting for biopsy. 

RT-PCR for feline coronavirus on effusion fluid or affected tissue is the most specific test. Combined with classic bloodwork (A/G ratio under 0.6, high globulins, low albumin, hyperbilirubinaemia in a young febrile cat), it provides high diagnostic confidence within days. 

Biopsy is invasive and slow. Bloodwork, ultrasound, effusion analysis with Rivalta, and PCR usually provide enough certainty to begin the 84-day GS-441524 protocol. Biopsy is reserved for genuinely ambiguous cases. 

Treatment should start as early as possible, ideally within the first 1 to 2 weeks of clinical signs. FIP progresses fast, and early treatment with GS-441524 is consistently linked to better survival and recovery. Delaying treatment for diagnostic certainty is the most common cause of poor outcomes. 

Many UK vets now actively support GS-441524 treatment and will monitor bloodwork, hydration and weight gain throughout the 84-day protocol. If your current vet is not experienced with FIP, CureFIP™ can help you connect with clinicians who are, and our team has supported a network of 100,000+ cats treated since 2019.




Πηγή: FIP Diagnosis UK: A Cat Owner's Fast-Track Guide: curefip (11 Ιουνίου 2026) at https://www.curefip.com/post/fip-diagnosis-uk-cat-owners-guide



σσ: Οι παραπάνω πληροφορίες είναι απολύτως σύμφωνες με την εμπειρία μου. Πριν από μερικά χρόνια (2020 και 2022), είχα την οδυνηρή εμπειρία να χάσω τρία πολύ νεαρά δικά μου γατιά (δύο θηλυκά και ένα αρσενικό), η κλινική εικόνα (αρχικά) και η νεκροψία (εκ των υστέρων) συνηγορούσε με υποψία FIP. Λίγο αργότερα, χρησιμοποίησα το GS-441524 σε δύο περιστατικά (ένα με νευρικά, 9 μηνών θηλυκό, και ένα με οφθαλμικά ΣΥΝ νευρικά και γενικά συμπτώματα, 4 μηνών επίσης θηλυκό, που είχαν μείνει για μεγάλο χρονικό διάστημα αδιάγνωστα και είχαν λάβει διάφορα φάρμακα χωρίς αποτέλεσμα), με ΠΟΛΥ ΕΝΤΥΠΩΣΙΑΚΗ ΑΝΤΑΠΟΚΡΙΣΗ (πλήρη ίαση χωρίς υποτροπή). Το πρώτο ήταν ένα πρώην αδέσποτο σε σπίτι με πάρα πολλές γάτες, που άρχισε να παραπατάει και να πέφτει, λίγες μέρες αφότου στειρώθηκε (όχι από μένα). Το δεύτερο ήταν ένα "κουρελάκι" που βρέθηκε παρατημένο σε κάτι χωράφια, και είχε τα χίλια μύρια (ασιτία, επιμονή διάρροια, αναπνευστικά, άφθονα παράσιτα, συν -όπως τελικά αποδείχτηκε- FIP). Έφτασε στο χείλος του θανάτου με βαριά επιληψία και τύφλωση, και επανήλθε (θεαματικότατα) μέσα σε λίγες ημέρες. Αυτά τα δύο τελευταία γατιά ήταν η "Νανού" και το "Λαχανάκι" που μου έδωσαν μεγάλη χαρά και θέλω να θυμάμαι τ' όνομα τους.




Πολύ εμπεριστατωμένη περιγραφή σχετικά με την διάγνωση και θεραπεία της νόσου για φροντιστές, βρήκα επίσης κι' εδώ (Μάιος 2026): https://catfriendly.com/wp-content/uploads/2026/05/FIP_Guide_FINAL.pdf [https://catfriendly.com/feline-diseases/fip/]





Τετάρτη 21 Ιανουαρίου 2026

Cat disease challenges what scientists thought about coronaviruses











Researchers at the University of California, UC Davis, have uncovered new details about how a once-deadly coronavirus disease in cats spreads through the immune system. The findings may help scientists better understand long COVID and other long-lasting inflammatory illnesses in people. The disease, feline infectious peritonitis or FIP, is caused by a form of feline coronavirus that changes inside some cats. If left untreated, it is almost always fatal. 

While FIP only affects cats, it shares many features with serious coronavirus-related conditions in humans να, including severe inflammation that can damage multiple organs, as well as symptoms that can persist or returnFor years, the prevailing belief was that the virus behind FIP infected just one type of immune cell. “What we found is that it actually infects a much broader range of immune cells, including those that are critical for fighting infection,” said lead author Amir Kol, associate professor with the UC Davis School of Veterinary MedicineThe study was published in the journal Veterinary Microbiology.


The researchers examined lymph node samples from cats with naturally occurring FIP. Lymph nodes are key immune system hubs where white blood cells gather and coordinate responses to disease. The team found viral material inside several types of immune cells - including B lymphocytes, which produce antibodies, and T lymphocytes, which help the immune system recognize and eliminate infected cells. They also found evidence that the virus was actively replicating itself inside these immune cells, rather than simply leaving behind harmless fragments. 

In people with severe or long-lasting coronavirus illnesses, scientists suspect that the virus may persist in the body or continue to disrupt the immune system. Studying this directly in humans is difficult, because doctors rarely have access to immune tissues such as lymph nodes. “This is where cats give us a unique opportunity,” Kol said. “We can directly study infected immune tissues in a naturally occurring coronavirus disease - something that’s very difficult to do in people.” 

The researchers also found that traces of the virus could remain in immune cells even after antiviral treatment ended and cats appeared healthy. Because some immune cells can live for years, this lingering infection could help explain long-term immune problems or disease relapse. The findings suggest that FIP may serve as a valuable real-world model for understanding how coronaviruses interact with the immune system over time. Insights gained from cats could help guide future research into chronic inflammation and post-viral syndromes in humans, including long COVID*By bridging veterinary and human medicine, the study highlights how naturally occurring diseases in animals can help answer critical questions about human health. 

Other authors of the study include Aadhavan Balakumar, Patrawin Wanakumjorn, Kazuto Kimura, Ehren McLarty, Katherine Farrell, Terza Brostoff, Jully Pires, Tamar Cohen-Davidyan, Jennifer M. Cassano, Brian Murphy and Krystle Reagan of UC Davis. Funding for the study was provided by the National Institutes of Health and the Sock-FIP fund at the Center for Companion Animal Health at the UC Davis School of Veterinary Medicine. It was also supported by the Faculty of Veterinary Medicine at Kasetsart University in Thailand.



Source: https://www.eurekalert.org/news-releases/1112335

https://www.ucdavis.edu/health/news/cat-disease-challenges-what-scientists-thought-about-coronaviruses 

Image at https://www.sciencedirect.com/science/article/pii/S0378113525005000 

Photo

Relative article in Greek at https://www.diagnovet.gr/anathewrhsh-tou-tropou-drashs-twn-koronoiwn-mesw-ths-loimwdous-peritonitidas-ths-gatas/


*CNN -> sciencealert


 


Κυριακή 22 Δεκεμβρίου 2024

Diagnosing FIP: how much diagnostic info is enough?



The diagnosis of  FIP has a reputation for being challenging, but can often be fairly straight forward. With the advent of anti-viral treatment, there is now an additional diagnostic option, since a positive response to FIP anti-viral treatment is itself diagnostic
The option of treatment also presents the challenge in shifting diagnostic patterns and goals to balance both time and financial resources between diagnostics and treatment. Initiating treatment quickly can be key to success, especially for wet FIP or FIP cats in critical condition. FIP can be difficult to definitively diagnose, but it's not necessary, and rarely advantageous, to exhaust all diagnostic options, since response to treatment can itself be the confirming diagnostic for a presumptive diagnosis. 

So how much diagnostic info is enough? It depends on the situation -- what pieces of information you have, how strongly the history, signalment, and diagnostics that you do have point to FIP, as well as the stability of the patient, and the financial constraints of the owner. 


History and signalment are important guides here. For example: A young male cat who was recently neutered and now presents as febrile and lethargic, with bloodwork showing A/G = 0.4 and lymphopenia. In a case such as this further diagnostics (other than exams to check for presence of ocular or neurological involvement, as that would affect the treatment plan) should not be necessary to arrive at a presumptive diagnosis of FIP. If a mature adult cat were to present in this way, further workup (ultrasound, etc) would not be unreasonable -- however a treatment trial would still be a valid option. 

When effusion is present in a young cat, confirming that the distention is due to ascites and  sampling it to confirm that it is consistent with effusion due to FIP, is probably enough to begin discussion about a treatment trial due to the rapid progression of effusive FIP. Further diagnostics can be continued in parallel if necessary. 

In cases where the diagnostic picture is more cloudy, a treatment trial may be preferable to invasive procedures like biopsy or exploratory surgery, both from the standpoint of impact on the patient, and financially for the owner. 


While it can be difficult or impossible to get definitive identification of FIP, in most cases a confident diagnosis can be made from a variety of evidence and diagnostics. Making a diagnosis relies on building a "diagnostic wall" of evidence as appropriate to the case. 

The first place to start is to obtain the history and signalment of the cat, and consider the symptoms as presented upon exam and from description of the owner. Important factors to consider are: 

  • Age: 70% of FIP cases occur in cats 1.5 years of age or less 
  • Breed: Pure-bred cats have three times greater incidence of FIP than random-bred cats due to genetic factors passed in bloodlines. 
  • Origin: Cats from crowded or stressful multi-cat environments (for example hoarding situations, crowded shelters) are more likely to develop FIP. 

Profiles of cats who developed FIP commonly show the following in their history: ​

  • failure to thrive​ 
  • recent stressful event  (surgery, re-homing, vaccination, other illness) 
  • weight loss 

Common symptoms that should raise suspicion for FIP:​ 

  • cyclical antibiotic-unresponsive 
  • fever
  • jaundice
  • abdominal distention (with suspicion of ascites) 
  • dyspnea (suspicion of pleural fluid)​ 
  • uveitis or retinitis (unilateral or bilateral) 
  • neurological symptoms (ataxia, seizures, rear leg weakness, changes in gait, tremors, etc)


When doing the exam, for treatment purposes, it is NOT of importance to treatment to differentiate between wet and dry FIP, however it is crucial to ascertain if neurological or ocular symptoms are present, as this will affect the dosing and treatment plan necessaryA basic eye and neurological exam (evaluation of gait, wheelbarrow, positioning, placement, etc. tests) is very important and necessary. Neurological and ocular symptoms can be present with any form of FIP, however they present more commonly with dry FIP than with wet FIP. 

The next step is basic diagnostic tests. Obtaining a CBC and chemistry panel is useful for both diagnostic purposes and to serve as a baseline for treatment progress and is therefore recommended. Note though that not all cats will have strong indications of FIP in bloodwork, and that ocular and neurological FIP often compartmentalizes in the brain and eyes and can often present with unremarkable bloodwork. 


Important:
A FECV titer is NOT diagnostic for FIP, and neither a positive nor negative result should be used to confirm or rule out FIP. FECV antibody titers can vary greatly over time, therefore measurement of a single antibody titer at a single random time point is not diagnostically significant. High and rising titer values can also be found in healthy FECV-infected cats, particularly in conjunction with FECV reinfection and therefore cannot confirm a suspicion of FIP. Similarly, a negative FECV antibody test result does not exclude FIP. Low or negative titers are seen in cats with both wet and dry FIP. In fact approximately 10% of cats with FIP do not have serum antibodies. FECV titer testing is not recommended and discouraged except in very rare cases. 


The following bloodwork findings are of diagnostic significance (but are not definitive): 

  • anemia 
  • leukocytosis usually associated with neutrophilia and lymphopenia 
  • hyperproteinemia with hyperglobulinaimia​, hypoalbuminemia, and  albumin: globulin ratio <0.6 
  • hyperbilirubinemia (and associated hyperbilirubinuria, due to destruction of red blood cells) 
  • may or may not have abnormal hepatic values. 

When analyzing bloodwork, it is important to remember that none of these  findings are present in all cats with FIP, and many other conditions can cause any of these findings. FIP cannot be definitely diagnosed or ruled out based on bloodwork alone. For example, while an A/G ratio of less than 0.6 is a classic diagnostic finding for FIP, FIP cats of all forms have been found to have higher ratios -- and conversely many conditions, including common ones like dental disease can cause an A/G ratio below 0.6. 


Diagnostic imaging can often be indicated to detect the presence of effusion, and/or organ or central lymph node involvement. Findings of diagnostic significance would include: 

  • ascites (abominal, pleural, or pericardial) 
  • abdominal lymphadenopathy, particularly mesenteric lymph node 
  • organomegaly in many different organs, including the heart may be affected.​ Cardio involvement can present similarly to HCM 
  • evidence of granulomatous changes or masses.


Similar to the hematological findings, it is important to remember that none of these  findings are present in all cats with FIP, and many other conditions can cause any of these findings. 

In cases where neurological FIP is suspected, MRI may be indicated to look for changes consistent with FIP. 

When ascites is present, there are several tests that are diagnostically significant. Importantly a FIP PCR test can be run on ascites fluid and some of these can provide definitive confirmation of FIP (although it cannot rule it out). Ascites fluid from FIP typically appears: 

  • Yellow (due to bilirubin) 
  • Mucinous (sticky or stringy)

The Rivalta test is a quick, inexpensive test which can can be run in-house with only distilled water and vinegar or acetic acid.  Instructions can be found here. The Rivalta test does not detect the FIP virus. Instead, it differentiates between a differentiate a transudate from an exudate. This test has a 86% PPV and 97% NPV for FIP.

Fluid analysis/cytology findings include: 

  • protein > 3.5 g/dl 
  • low cellularity 
  • non-degenerative neutrophils, monocyte/macrophages, large foamy macrophages, lymphocytes

RT-PCR Tests can detect specific mutations of FECV -- in some tests (IDEXX) they are able to specifically identify the biotype as FIP vs FECV. 

  • Very good specificity and fair sensitivity for effusion but it is not useful for blood
  • Positive results are considered reliable, but there is approximately a 30% false negative rate meaning that a negative result cannot rule out FIP. 

One note of significance with these tests is that the turnaround time to get a result may affect the choice as to which tests are appropriate or whether or not it is prudent to start treatment in parallel with diagnosis: a Rivalta test can be done immediately, protein values on fluid can be done in house or usually with 24 hour turnaround from a diagnostic lab, but RT-PCR tests frequently require as much as a week before getting results.

When there are inflamed lymph nodes or other lesions, a fine needle aspirate can be obtained and can also be tested via RT-PCR. Invasive biopsies and exploratory surgeries should generally be avoided unless absolutely necessary -- a treatment trial often is more appropriate in those cases.

RT-PCR tests can also be run on aqueous humor (when there is ocular involvement) and CSF samples


Source: FIP Treatment Guide for Veterinary Professionals  at https://www.fipvetguide.com/diagnosing-fip

For cat owners, info here: https://www.fipvetguide.com/resources-for-owners

                                                                


More valid info about FIP: 


















And about Niel Pedersen, see here: https://www.zenbycat.org/photographer/niels-pedersen

Σάββατο 23 Νοεμβρίου 2024

Νευρική μορφή της λοιμώδους περιτονίτιδας της γάτας

 

Οι γάτες που νοσούν από λοιμώδη περιτονίτιδα (FIP) παρουσιάζουν νευρικά συμπτώματα σε ποσοστό μεγαλύτερο από 30 τοις εκατό. Τα συμπτώματα αυτά οφείλονται σε εστιακές, πολυεστιακές ή διάχυτες αλλοιώσεις που εντοπίζονται στον εγκέφαλο, στον νωτιαίο μυελό και στις μήνιγγες. Πολλές φορές, η λοιμώδης περιτονίτιδα ευθύνεται  για την πρόκληση μηνιγγοεγκεφαλίτιδας στις γάτες. 

Τα νευρικά συμπτώματα συνοδεύουν συχνά  την μη διαχυτική (ξηρή) μορφή της νόσου, είτε μόνα τους, είτε μαζί με συμπτώματα από άλλα οργανικά συστήματα, ως μέρος της συνολικής κλινικής εικόνας. Σε ορισμένες περιπτώσεις όμως, η νόσος εμφανίζεται ύπουλα, χωρίς συμπτώματα από άλλα συστήματα, και οι γάτες παρουσιάζουν μόνο νευρικές εκδηλώσεις, οι οποίες οφείλονται σε πυοκοκκιοωματώδη αγγειίτιδα, διαμεσολαβούμενη από ανοσοσύμπλοκα και εντοπιζόμενη στις μήνιγγες, τον εγκεφαλικό ιστό και το χοριοειδές πλέγμα του κεντρικού νευρικού συστήματος. Λόγω δε της φλεγμονώδους απόφραξης του αγγειακού συστήματος, ενδέχεται να εκδηλωθεί ακόμα και δευτεροπαθής υδροκέφαλος. 

 Οι οφθαλμικές βλάβες περιλαμβάνουν πρόσθια ραγοειδίτιδα, ιριδίτιδα, ιζήματα στον κερατοειδή, αμφιβληστροειδίτιδα και ανισοκορία. Οι προσβεβλημένες γάτες μπορεί να παρουσιάζουν ταυτοχρόνως και γενικά συμπτώματα, όπως ανορεξία και απώλεια σωματικού βάρους. 

Σε μια αναδρομική μελέτη νευρικής μορφής FIP, εντοπίστηκαν τρία κλινικά σύνδρομα σύνδρομα: Τ3-L3 μυελοπάθεια (Θ3-Ο3), σύνδρομο του κεντρικού αιθουσαίου συστήματος, και πολυεστιακή νόσος του ΚΝΣ (Κεντρικού Νευρικού Συστήματος). 

Οι συνήθεις νευρικές εκδηλώσεις περιλαμβάνουν αταξία, πάρεση, υπεραισθησία, νυσταγμό, επιληπτικές κρίσεις, αλλαγές στην συμπεριφορά και την νοητική λειτουργία, και λειτουργική ανεπάρκεια των κρανιακών νεύρων. 

Το Ευρωπαϊκό Συμβουλευτικό Συμβούλιο για τις Ασθένειες της Γάτας (European Advisory Board on Cat Diseases - ABCD) έχει δημιουργήσει ένα διαγνωστικό εργαλείο που περιλαμβάνει μια σύνοψη των κριτηρίων που θεωρούνται απαραίτητα για την πιστοποίηση πιθανότητας της νόσου (Tasker et al., 2022)

Στο σημείο αυτό θα πρέπει να δοθεί έμφαση στο εξής: Η τεκμηρίωση της διάγνωσης, ιδίως της μη διαχυτικής (ξηρής) μορφής FIP, δεν μπορεί να βασιστεί μόνο στον θετικό τίτλο όρου, ενώ ο αρνητικός τίτλος δεν αποκλείει την πιθανότητα νευρολογικής νόσου που σχετίζεται με FIP, καθώς τα ανοσοσυμπλέγματα μπορούν να διαφύγουν της ανίχνευσης με τυπικές δοκιμές.

Δεδομένου ότι σήμερα υπάρχουν πλέον διαθέσιμα αντιικά φάρμακα αποτελεσματικά για την θεραπεία της FIP (όπως το νουκλεοσιδικό ανάλογο GS-441524), η θεραπευτική δοκιμή κρίνεται απολύτως θεμιτή και πολύ χρήσιμη για τον κλινικό κτηνίατρο - πόσω μάλλον που οι παρενέργειες δεν είναι σοβαρές, ενώ η θεραπευτική ανταπόκριση είναι πολύ γρήγορη. Τα γλυκοκορτικοειδή, αν και στο παρελθόν έχουν χρησιμοποιηθεί για την παρηγορητική θεραπεία της FIP, θα πρέπει να αποφεύγονται καθώς φαίνεται ότι, όχι μόνο συσκοτίζουν την κλινική και ορολογική εικόνα εικόνα αλλά παρεμποδίζουν και το θεραπευτικό αποτέλεσμα.


Πηγή: Άρθρο της νευρολόγου κτηνιάτρου Simona Radaelli* με τίτλο "Neurological feline infectious peritonitis"at https://www.veterinary-practice.com/article/neurological-feline-infectious-peritonitis (Μάρτιος 2024)


*https://improveinternational.com.au/speakers/simona-radaelli/ -- https://www.vvs.vet/simona-radaelli-neurology-specialist/ 



More info about FIP:


Even more: 


+ ένα ΠΟΛΥ ΠΡΟΣΕΓΜΕΝΟ άρθρο ελληνικά (βλ. παράγραφο για τους παράγοντες που προδιαθέτουν την μετάλλαξη του FCoV σε FIP, μεταξύ των οποίων η ηλικία, η φυλή, το stress και η προσβολή από άλλους ιούς όπως ο ιός FeLV)




Τετάρτη 18 Σεπτεμβρίου 2024

Τα τελευταία δεδομένα για την διάγνωση και θεραπεία της λοιμώδους περιτονίτιδας της γάτας (FIP)


by Maria LyrakiDVM MSc 



Feline coronavirus (FCoV) is the causative agent of the serious disease of feline infectious peritonitis (FIP). FCoV has a cell tropism for the enterocytes and usually causes clinical signs of enteritis or no clinical signs at all. 

Being an RNA virus though, FCoV has a high level of genetic variation due to frequent errors (mutations) during RNA replication. The hypothesis is that these mutations can occasionally facilitate the switching of cell tropism from a mostly mild enteric (less-virulent) FCoV pathotype to an FIP-associated FCoV pathotype. 

When FIP develops, the replicating FCoV in monocytes causes damage to the blood vessel walls, allowing plasma to leak out of the vessels; this can appear clinically as an effusion in the abdominal, thoracic and/or pericardial cavities (wet FIP form). In more chronic forms of FIP, granulomas result on affected organs (dry FIP form). Dry FIP can involve any organ, including nervous system (neurological form) and eyes (ocular form). 

Feline infectious peritonitis (FIP) is considered fatal unless treated promptly with the appropriate antiviral treatment. Various antiviral drugs have shown promising results in vitro. The mainstay of treatment at present is the nucleoside analogue GS-441524 and its prodrug remdesivir with multiple studies showing clinical efficacy ranging from 81.3 - 88.6% and no relapse for the responders up to one year after treatment. The nucleoside analogue molnupiravir has also been used with success. The protease inhibitor GC376 also appears effective in the injectable form, although oral effectiveness appears to be inferior to GS-4415249. 

These antiviral treatments act quickly, with fever and other clinical signs often improving markedly within a few days, allowing the clinician to attempt trial treatment of cats in which FIP is very likely but cannot be confirmed. Most studies have used 84-day treatment courses, but evidence has now been published that shorter courses of 42 days may be equally effective for cats with effusions; such shorter courses will enable improved access to treatment for cost and/or compliance reasons.

Despite the significant progress in treatment that has happened over the last few years, FIP remains a challenging disease for the clinicians for several reasons: 

1. It is often difficult to obtain a definitive diagnosis. Although effusive and non-effusive forms of FIP are described, there is much overlap between these forms and the clinical signs of FIP can change over time. Invasive diagnostic tests are often needed to secure diagnosis, but they carry a risk of the patient deteriorating. 

2. The antiviral treatment is often expensive, not licensed and not available legally in many countries. Some countries have access to veterinary compounded antiviral products whereas others have access to antivirals developed for humans such as remdesivir or molnupiravir. In others, owners source antivirals themselves online, but the quality, purity, and concentration of active ingredients in these preparations is usually unknown, and can be variable, although they are often effective.

3. The ideal drug dose and duration of treatment is not certain yet. It is commonly believed that the neurological and ocular cases may need higher dosages due to the blood-brain and blood-ocular barriers. 

4. Acute phase proteins are an integral part of treatment monitoring. Nevertheless, they are not specific for FIP and clear guidelines as to how they can guide treatment decisions are lacking. 

5. Since the outbreak of feline infectious peritonitis (FIP) in Cyprus, caused by FCoV-23, new combination of cat and dog coronaviruses, there is urgent need to understand modes of transmission and treatment options for "traditional" FIP versus FCoV-23, as new or similar outbreaks may occur world-wide. 

Considering the challenges above, the upcoming lecture will further focus on clinical FIP case scenarios. The cases that will be presented will serve as a practical guide to diagnosis, treatment and monitoring that can help individualising drug dose and treatment duration on a case-basis. Furthermore, the attendant will gain an insight into novel monitoring tools that are expected to revolutionize FIP treatment soon, such as Therapeutic Drug Monitoring (TDM) and viral load assessment.

TDM involves measuring blood concentrations of the active metabolite of the antiviral drugsuch as EIDD-1931 and GS-441524. This will allow for a greater understanding of how individual cats metabolise these drugs to avoid underdosing as a reason of treatment failure (because of poor absorption and/or rapid excretion in urine). Furthermore, certain antiviral drugs such as molnupiravir have been associated with dose-dependent toxicity and TDM will ensure that overdose is avoided. Optimising drug treatment should improve the prognosis for individual cats. 

Viral load assessment involves measuring FCoV load by PCR with quantification in blood, faeces, fluid or tissue before, during and after treatment. This will show how quickly these drugs clear FCoV from blood and stools, helping to reduce new infections and to tailor the duration of treatment for the individual patient.




Πηγή
: NEW AND OLD TREATMENT OPTIONS FOR FELINE INFECTIOUS PERITONITIS: 
INDIVIDUALISING TREATMENT 

at https://fecava2024.org/wp-content/uploads/2024/09/Proceedings-Book-v05-1.pdf, σελ. 57-59


(29th FECAVA Eurocongress 2024 & 12o Eλληνικό Συνέδριο Κτηνιατρικής Ζώων Συντροφιάς E.K.E)


References:

1. Tasker S. GUIDELINE for Feline Infectious Peritonitis (Internet). ABCD European Advisory Board on Cat Diseases; 2024 Jun (cited 2024 July 26). Available from: https://www.abcdcatsvets.org/guideline-for-feline-infectious-peritonitis/

2. Barua S, Kaltenboeck B, Juan YC, Bird RC, Wang C. Comparative Evaluation of GS-441524, Teriflunomide, Ruxolitinib, Molnupiravir, Ritonavir, and Nirmatrelvir for In Vitro Antiviral Activity against Feline Infectious Peritonitis Virus. Vet Sci. 2023 Aug 9;10(8):513:  https://doi.org/10.3390/vetsci10080513

3. Coggins SJ, Norris JM, Malik R, Govendir M, Hall EJ, Kimble B, Thompson MF. Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS‐441524. Viruses. 2022 Nov 1;14(11):2429: https://doi.org/10.1111/jvim.16803

4. Taylor SS, Coggins S, Barker EN, et al. Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020-2022). J Feline Med Surg. 2023 Sep;25(9):1098612X231194460: https://doi.org/10.1177/1098612X231194460

5. Green J, Syme H, Tayler S. Thirty-two cats with effusive or non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524. J Vet Intern Med. 2023 Sep-Oct;37(5):1784-1793. DOI: 10.1111/jvim.16804

6. Zwicklbauer K, Krentz D, Bergmann M, et al. Long-term follow-up of cats in complete remission after treatment of feline infectious peritonitis with oral GS-441524. J Feline Med Surg. 2023 Aug;25(8): https://doi.org/10.1177/1098612X231183250

7. Sase O. Molnupiravir treatment of 18 cats with feline infectious peritonitis: A case series. J Vet Intern Med. 2023 Sep-Oct;37(5):1876-1880: https://doi.org/10.1111/jvim.16832

8. Roy M, Jacque N, Novicoff W, Li E, Negash R, Evans SJ. Unlicensed Molnupiravir is an Effective Rescue Treatment Following Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis. Pathogens. 2022 Oct 20;11(10):1209. DOI: 10.3390/pathogens11101209

9. Yan Y, Li J, Jiao Z, Yang M, Li L, Wang G, Chen Y, Li M, Shen Z, Shi Y, Peng G. Better therapeutic effect of oral administration of GS441524 compared to GC376. Veterinary Microbiology 2023. DOI: 10.1016/j.vetmic.2023.109781

10. Zuzzi-Krebitz AM, Buchta K, Bergmann M, Krentz D, Zwicklbauer K, Dorsch R, Wess G, Fischer A, Matiasek K, Hönl A, et al. Short Treatment of 42 Days with Oral GS-441524 Results in Equal Efficacy as the Recommended 84-Day Treatment in Cats Suffering from Feline Infectious Peritonitis with Effusion—A Prospective Randomized Controlled Study. Viruses 2024, 16, 1144: https://doi.org/10.3390/v16071144

11. Kent AM, Guan S, Jacque N, Novicoff W, Evans SJ. Unlicensed antiviral products used for the at-home treatment of feline infectious peritonitis contain GS-441524 at significantly different amounts than advertised. J Am Vet Med Assoc. 2024 Feb 7:1-9. DOI: 10.2460/javma.23.08.0466

Κυριακή 7 Ιουλίου 2024

Η λοιμώδης περιτονίτιδα της γάτας τώρα θεραπεύεται

 

FIP in Cats: What Every Owner Needs to Know 

FIP - three initials that strike fear into every cat owner who knows how deadly this disease can be. While the virus that causes FIP is incredibly common, up until now treatment has been hopeless. Thankfully, there could soon be a brand new treatment that offers an infected cat a much better chance of survival. What exactly is FIP and are there any new treatments out there because this disease scares so many cat owners: FIP stands for Feline Infectious Peritonitis and is caused by a cat-specific coronavirus that poses no risk to humans.

In most cats, the coronavirus normally stays in the intestines and either causes no problems or just mild diarrhea. Infection in this way is really common, with about 40% of household cats becoming infected at some point in their lives. For cats living in the same home as other cats, infection is even more common with about 60% being infected. In cat colonies, infection rates are pretty much 100%.


In a small proportion of cats, there is a mutation* of the virus which results in one of the body’s white blood cells, the macrophage, becoming infected. Once this mutation takes place, the virus then readily replicated in these cells and is carried around the rest of the body. At this stage, the body’s immune system may recognize and destroy the virus, preventing infection. If the immune system is not able to kill this new FIP virus, there is a reaction between the immune system and virus. This causes inflammation of the blood vessels, known as vasculitis, and the disease known as FIP.


FIP is most commonly seen in young cats, with 80% being under 2 years of age and the majority of these being between 4 and 12 months old. The disease is more common in cats living in more crowded and stressful living conditions, such as multi-cat households and breeding colonies. Genetics may also be a role as certain breeds, include the Abyssinian, Bengal, Birman, Himalayan, Ragdoll, and Devon Rex appear more prone to developing FIP. Other purebred cats, such as Burmese, Exotic Shorthairs, Manxes, Persians, Russian Blues and Siamese, are at no extra risk from FIP. Overall, Feline Infectious Peritonitis is thought to kill about 1% of cats worldwide.


The early signs of FIP can be vague and non-specific, and this phase can last for days to months: Fever, Lethargy, Inappetence. Once the disease progresses, there are 2 forms, wet FIP and dry FIP, which have different symptoms and different diagnostic challenges.

In wet FIP, the blood vessels become leaky which results in fluid building up somewhere in the body. This is most often in the abdomen followed by the chest. The fluid often has a fairly characteristic appearance - clear yellow, thick, and “sticky”.

In dry FIP inflammatory lesions form around the blood vessels. This most commonly affects the eyes or brain**, but can also affect the kidneys, liver, lungs, and skin. Signs of dry FIP are often still vague, and depend on the areas of the body most seriously affected. In a cat showing some FIP symptoms, the cat’s age, breed, and lifestyle are considered. A young cat of an at-risk breed, living in a multicat environment is much more likely to be suffering from FIP than an older cat who does not have contact with others. Blood testing is then likely to be carried out.

Unfortunately, there is no specific FIP blood test. A titer test can be run, but this can only check for coronavirus exposure. This is not helpful if positive, as most cases of coronavirus infection are "normal" intestinal infections, and there is no way to differentiate this from FIP infection. A negative result, however, is likely to mean that FIP can be ruled out.There are some common, non-specific, changes in general blood test parameters that don’t confirm FIP but, if present, give another clue FIP could be the cause of a cat’s illness.

If fluid is present within the abdomen or chest, then this can be sampled. Feline Infectious Peritonitis fluid is normally clear, yellow, thick and sticky in character, and high in protein when tested. The fluid can also be checked for the presence of coronavirus within the fluid itself. Again, this test can’t differentiate between the intestinal and FIP versions of coronavirus but if found in the fluid, then infection is much more likely.

Finally, biopsy of affected tissues can be carried out. This is a much more invasive test requiring anesthetic and surgery. Because a cat is normally very unwell by this stage, it is not a test that is commonly carried out because of the high risk involved.

Unfortunately, FIP is currently a fatal disease in cats. Once an individual becomes unwell, they will often die only days to weeks later. Treatment involves providing supportive, symptomatic care but all this really does is delay their inevitable death.


There is hope on the horizon that there may soon be a new FIP treatment that really works! This is a human antiviral drug currently known as "GS-441524". In the initial study***, 31 cats with FIP were treated with 26 completing the planned 12 weeks of treatment: 1 cat subsequently died from FIP, another from heart disease, 18 remain healthy with no further treatment needed, 8 cats required repeat treatment but were also health when the study was published. These surviving cats, at the time of publishing of the study, were last treated between 9 months and 20 months previously. This means that a massive 77% of cats not only survived FIP, but remained healthy for at least 9 months after infection. I’m sure there will be more studies looking into the long-term survival of cats with FIP treated with GS-441524. And I’m also sure we’ll be calling this drug by a different name!


While there is a vaccine available in some countries, it is generally not recommended. This is because it should only be administered to a kitten older than 16 weeks that have no antibodies to coronavirus. This rules out most at-risk cats. If you are bringing a new kitten of an at-risk breed into a house with multiple cats, however, and the vaccine is available, there is no harm in getting them titer tested and then vaccinated if negative.


Other prevention strategies include: Keeping fewer cats living together - the more cats the higher the risk, meticulous hygiene, low stress and good general care.


One important fact to remember too is that in most cases, the FIP version of coronavirus is not shed in an infected cat’s poop. As a result, FIP is not readily transmitted from one infected cat to another. It is the standard, common, intestinal coronavirus mutating within a cat that results in FIP.


Source: https://ourpetshealth.com/podcast/fip-in-cats?rq=FIP [Sept. 2020]


*The exact trigger for the mutation is still unknown. General observations indicate that low immunity due to stress, neutering, and poor living condition may causeh the onset of the FCOV mutation into FIPV [basmifipturkey.com]. Although FIP can occur in cats of any age, it is most often seen in young cats. Around 80% of cases diagnosed are in cats less than 2 years old, and many cases are seen in kittens around 4-12 months old. FIP is also more common in cats kept in groups or colonies (especially breeding households) as this is an environment where FCoV infections are spread easily. A crowded environment may also contribute to stress, which can be a factor in disease development as it compromises the cat’s immune response. There is evidence that genetics can also play a role in susceptibility to disease, although this is complex. Many cats that develop FIP are now in single cat homes, despite coming from multi-cat environments [icatcare.org/advice].

** https://m.youtube.com/watch?si=L_Sfarlqo1UPkj_L&v=xeACdrksmTs&feature=youtu.be


***Dr. Niels Pedersen’s initial study (2019): https://journals.sagepub.com/doi/full/10.1177/1098612X19825701

Dr. Niels Pedersen’s Publications by Year: https://www.lunasfiplegacy.com/research 

THE NEUROLOGICAL FORM OF FELINE INFECTIOUS PERITONITIS AND GS-441524 TREATMENT 

WHAT IS THE HISTORY OF FIP? (an interview with Dr. Niels C. Pedersen by Nancy Reeves , published in October 2008) at https://www.sockfip.org/about-fip/FIP was first recognized as a specific clinical entity in the late 1950’s. This timeline was based on decades of meticulous necropsy records kept by pathologists at the Angell Memorial Animal Hospital. There was a steady increase in the incidence of the disease in the 1960’s onward, and it is currently one of the leading infectious causes of death among young cats from shelters and catteries. The reason for the sudden emergence of FIP is not known, but there are at least two possible explanations. First, it is noteworthy that FIP appeared within a decade of the initial descriptions of transmissible gastroenteritis (TGE) of pigs in North America.The causative virus of FIP is closely related to TGEV of pigs and canine coronavirus (CCV), although they are still genetically distinguishable. However, mixtures between these three viruses are known to occur. At least one strain of canine coronavirus can induce mild enteritis in cats and enhance a subsequent infection with FIPV, indicating a special closeness to feline coronaviruses. Therefore, CCV may be a more likely parent of FECV in this scenario. Another related possibility is that the FIP mutation occurs only in a relatively new strain of FECV, and that this new strain only evolved in the 1950’s. Coronaviruses such as FECV are continuously mutating as a result of the manner in which their genetic material (RNA) is replicated. Therefore, genetic change, either among themselves or through genetic mixing with closely related coronaviruses from other species, could have either allowed a coronavirus of another species to take up host in cats or to alter a strain that existed prior to the 1950s. An alternative non-genetic explanation may involve changes in how cats were viewed as pets and their husbandry. There was a dramatic shift in the status, keeping, and breeding of cats as pets after WWII.The numbers of pet cats greatly increased, pure breeding and cattery rearing became increasingly popular, and more cats, and in particular kittens, found themselves in shelters. These large multiple cat indoor environments are known to favor feline enteric coronavirus (FECV) infection and FIP. Interestingly, feline leukemia virus (FeLV) infection also became rampant among indoor multiple cat households during this period, and FeLV infection was a significant enhancing factor for FIP until it was pushed back into nature as a result of testing, elimination/isolation, and eventual vaccination in the 1970s and 1980s. 

More 


See also 

GLOBAL RESEARCH ARTICLES



Update: There have been significant recent developments in the management of this once fatal condition. Initial research by Professor Niels Pedersen of University of California, Davis, showed that some newer anti-viral drugs, such as GC-376 and GS-441524, used in humans against some emerging viruses, were effective. Hope came in 2020-2021, when remdesivir and GS-441524 became legally available initially in Australia, then the UK and now via export to multiple countries around the world. Experience using these drugs has shown that most cats can be successfully treated (response is around 85%). The treatment course is long at 84 days, and most cats can be treated at home with tablets/liquid, but if very unwell, they may require the initial treatment in the veterinary clinic with injectable anti-viral drugs. A small number of cats don’t respond, and some require adjustments in treatment dosageRelapse of FIP is possible during or after the treatment course, but it is uncommon. Several publications have now followed cats after they have been treated for FIP with these anti-viral drugs, and the vast majority have remained healthy. We continue to learn more as we study this disease and other anti-viral drugs become legally available, such as molnupirivir, another anti-viral medication used legally in some countries with success. We look forward to learning more about the treatment of FIP over the next few years. Black market products remain available, but of unknown content and safety, so legal drugs should be selected for the treatment of FIP in cats. Please click here for more specific information about these drugs and speak to your vet to discuss treatment options if your cat is diagnosed with FIP. [https://icatcare.org/advice/feline-infectious-peritonitis-fip/, Nov. 2023]

Further information for veterinarians can be found here [May 2024]




Concerning feline infectious peritonitis outbreak in Cyprus (FCoV-2023-outbreak): biorxiv.orgicatcare.orgbvajournals.onlinelibraryfecavafipwarriors.euhvms.gr 

Σύμφωνα με τον κτηνίατρο Μάριο Μιχαήλ, εκατοντάδες ήταν και οι περιπτώσεις γάτων που μεταφέρθηκαν σε κτηνιατρικές κλινικές με συμπτώματα χτυπήματος από αυτοκίνητα, αλλά οι εξετάσεις έδειξαν τελικά πως επρόκειτο για νευρολογικά προβλήματα που προκαλούνται από την λοιμώδη περιτονίτιδα [dw]


More info: 




Articles at fipwarriors.eu


Drugs at fipwarriors.eu



Παλαιότερες αναρτήσειςfilikakiblogspot (Ιαν. 2021), gatouitiblogspot (Φεβρ. 2023)

Facebook linkssearchFIP Cats UKFIP Warriors Cyprus & GreeceFIP Veterinarians Education


Photo1 at https://www.basmifipturkey.com/blog










Λοιμώδης περιτονίτιδα της γάτας (FIP): τελευταία νέα, για κτηνιάτρους και φροντιστές που θέλουν να ξέρουν

  FIP ( Feline Corona Virus)  is caused by a mutation of the feline coronavirus (FCoV). It progresses quickly, and untreated cases are almo...